Our cross-tissue analysis allowed us to detect pan-cancer characteristics, and we suggest that stromal changes in NAT represent an emerging hallmark of cancer that may be essential for tumorigenesis and/or tumor progression. The gene discussed is BRD2; the disease is neoplasm.